Spots Global Cancer Trial Database for HLA Sensitization Following Major Cortical Allograft Bone Procedures

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: HLA Sensitization Following Major Cortical Allograft Bone Procedures

Official Title: HLA Sensitization Following Major Cortical Allograft Bone Procedures

Study ID: NCT00160719

Conditions

Bone Cancer

Interventions

retrieve blood samples

Study Description

Brief Summary: The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone.

Detailed Description: Patients who have bone cancer often have the cancerous bone removed by surgery and replaced with a piece of bone taken from a donor (a person who donates parts of their body to be used for transplants after their death). However, sometimes this replacement bone does not heal together with the patient's bone. The reason the bone does not heal is not known but it is thought that the patient's body may react to the donor bone by producing antibodies against cells on the donor bone. The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone. You have been asked to participate in this study because you are scheduled to undergo this type of surgery.